Sarcoma

Top Story

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016

Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a population-based cohort study.

The risk for cancer appeared greatest in the first 6 months after VTE.

In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…
FDA News

FDA grants orphan drug designation to tazemetostat for treatment of malignant rhabdoid tumors

February 8, 2016
The FDA granted orphan drug status to tazemetostat for the treatment of malignant rhabdoid tumors, according to a press release from the agent’s manufacturer.The…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and emphasize the importance…
In the Journals

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016
Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…
FDA News

FDA grants orphan drug designation to tazemetostat for treatment of malignant rhabdoid tumors

February 8, 2016
The FDA granted orphan drug status to tazemetostat for the treatment of malignant rhabdoid tumors, according to a press release from the…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…

Children’s Hospital Los Angeles names director of Center for Personalized Medicine

February 3, 2016
Jaclyn Biegel, PhD, has been named director of the Center for Personalized Medicine at Children’s Hospital Los Angeles.Biegel ― known for her…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
FDA News

FDA grants orphan drug designation to TRC105 for soft tissue sarcoma

February 1, 2016
The FDA granted orphan drug designation to TRC105 for the treatment of patients with soft tissue sarcoma.TRC105 (TRACON Pharmaceuticals) is a novel…
In the JournalsPerspective

Panel issues framework for allocation of scarce pediatric oncology drugs

January 29, 2016
Pediatric oncology and bioethics experts have issued a framework for the allocation of scarce drugs to reduce waste and prioritize treatment across…
FDA News

FDA approves Halaven for metastatic, unresectable liposarcoma

January 28, 2016
The FDA today approved the chemotherapy drug eribulin mesylate for the treatment of patients with unresectable or metastatic liposarcoma who…
In the Journals

Studies highlight potential for genomic testing in pediatric cancers

January 28, 2016
Precision medicine techniques such as whole-exome sequencing and tumor molecular profiling may improve the diagnosis and treatment of pediatric solid…
More Headlines »
morganatic-roan